Left Ventricular Myocardial Work Improves in Response to Treatment and is Associated with Survival Among Patients with Light-Chain Cardiac Amyloidosis.

amyloidosis echocardiography global longitudinal strain

Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
24 Dec 2023
Historique:
received: 26 07 2023
revised: 18 11 2023
accepted: 13 12 2023
medline: 24 12 2023
pubmed: 24 12 2023
entrez: 24 12 2023
Statut: aheadofprint

Résumé

Complete hematologic response to treatment for light chain cardiac amyloidosis (AL-CA) may lead to improvement of myocardial function and better outcomes. We sought to evaluate the effect of response to treatment for AL-CA on echocardiographic indices of myocardial deformation and work, and their prognostic significance. Sixty-one patients treated for AL were enrolled and underwent echocardiographic assessment at baseline and at 1-year. Patients were stratified according to hematologic response as complete or not complete responders. A significant reduction in median NT-proBNP (2,771 to 1,486 pg/mL; p < 0.001), posterior wall thickness (PWT) (13 to 12 mm; p = 0.002), and an increase in global work index (GWI) (1,115 to 1,356 mmHg%; p = 0.018) was observed at 1-year. Patients with complete response (CR) had a more pronounced decrease in intraventricular septum thickness (14.2 to 12.0 mm; p = 0.006), improved global longitudinal strain (GLS) (-11.6 to -13.1%; p for interaction = 0.045), increased global constructive work (1,245 to 1,436 mmHg%; p = 0.008) and global work index (926 to 1250 mmHg%, p = 0.002) compared to non-CR. Furthermore, deltaGLS (ρspearman = 0.35; p < 0.001) and deltaGWI (ρspearman = -0.32; p = 0.02) correlated with delta NT-proBNP. Importantly, patients with GLS and GWI response had a better prognosis (log-rank p = 0.048 and log-rank p = 0.007, respectively). After adjustment for Mayo stage, gender, and response status, deltaGLS (HR = 1.404, p = 0.046 per 1% increase) and deltaGWI (HR = 0.996, p = 0.042 per 1mmHg% increase) were independent predictors of survival. Complete hematologic response to treatment is associated with improved left ventricular myocardial work indices and their change is associated with improved survival in AL-CA.

Identifiants

pubmed: 38142437
pii: 7492923
doi: 10.1093/ehjci/jead351
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Alexandros Briasoulis (A)

Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Dimitrios Bampatsias (D)

Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Ioannis Petropoulos (I)

Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Athanasios Rempakos (A)

Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Raphael Patras (R)

Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Foteini Theodorakakou (F)

Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Nikolaos Makris (N)

Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Meletios Athanasios Dimopoulos (MA)

Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Kimon Stamatelopoulos (K)

Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Efstathios Kastritis (E)

Department of Clinical Therapeutics, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Classifications MeSH